Search results
Found 258 matches for
Unique study of vascular disease reaches 20th anniversary
Research Stroke & Dementia
19 April 2022
The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
Little understood brain region linked to how we perceive pain
Clinical Neurology Integrative Neuroimaging Research
28 March 2022
A new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.
New funding awarded to study persistent pain in inflammatory arthritis
Clinical Neurology Research
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Brain regions related to smell show decline following mild COVID-19
Coronavirus Integrative Neuroimaging Research
7 March 2022
Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
Attention and memory deficits persist for months after recovery from mild COVID
Clinical Neurology Coronavirus Research
19 January 2022
Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.
New Academic Visitor from Nigeria
Integrative Neuroimaging Research
19 January 2022
Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.
New spinout company: Human-Centric Drug Discovery
Clinical Neurology Research
7 January 2022
Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
Funding received for research into Motor Neuron Disease
Clinical Neurology Research
5 January 2022
A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia
Anaesthetics Coronavirus Research
17 December 2021
A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.
Protein test could lead to earlier and better diagnosis of Parkinson’s
Clinical Neurology Research
13 December 2021
Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
Nine new Professors
Award Research
8 December 2021
Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.
Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize
Clinical Neurology Coronavirus Research
19 November 2021
In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
Clinical Neurology Research
3 November 2021
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
Major research network to investigate body clock and stroke
Ophthalmology Research SCNi
27 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
COVID-19 infection has greater risk than vaccines of causing very rare neurological events
Clinical Neurology Coronavirus Research
27 October 2021
Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
Mapping uncharted networks in the progression of Parkinson’s
Clinical Neurology MRC BNDU Research
26 October 2021
A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
New genetic diagnosis technology for eye disease receives major funding award
Ophthalmology Research
12 October 2021
Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.
Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd
Award Clinical Neurology Research
8 October 2021
Mapping brain network activity from structural connectivity using deep learning
Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness
Award Clinical Neurology Research
30 September 2021
Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.